Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,631554,Bp133,Blood pressure QTL 133,,0.005,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,764421,66221621,Rat,n/a,region,qtl 1000,2293680,Bss40,Bone structure and strength QTL 40,5.66,0.0001,femur strength trait (VT:0010010),femur total energy absorbed before break (CMO:0001677),10,1,35538813,Rat,n/a,region,qtl 1000,7411611,Foco17,Food consumption QTL 17,18.7,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),10,1,42669970,Rat,n/a,region,qtl 1000,634327,Hc4,Hypercalciuria QTL 4,2.4,,urine calcium amount (VT:0002985),urine calcium excretion rate (CMO:0000763),10,1,38594330,Rat,n/a,region,qtl 1000,10401803,Kidm50,Kidney mass QTL 50,,,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),10,1,44902893,Rat,n/a,region,qtl 1000,1549898,Neuinf3,Neuroinflammation QTL 3,26.4,,nervous system integrity trait (VT:0010566),MHC Class II RT1A-positive spinal cord ventral horn area to total spinal cord ventral horn area ratio (CMO:0001980),10,2847625,5460218,Rat,n/a,region,qtl 1000,1576304,Schws7,Schwannoma susceptibility QTL 7,,0.0115,nervous system integrity trait (VT:0010566),percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017),10,4835638,20170031,Rat,n/a,region,qtl 1000,7387235,Uae41,Urinary albumin excretion QTL 41,5.26,0.1874,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),10,1,29592136,Rat,n/a,region,qtl